Advertisement

Journal of Bioethical Inquiry

, Volume 6, Issue 2, pp 171–179 | Cite as

Effective use of a Limited Antiviral Stockpile for Pandemic Influenza

  • Nimalan ArinaminpathyEmail author
  • J. Savulescu
  • Angela R. Mclean
Article
  • 158 Downloads

Abstract

Just allocation of resources for control of infectious diseases can be profoundly influenced by the dynamics of those diseases. In this paper we discuss the use of antiviral drugs for treatment of pandemic influenza. While the primary effect of such drugs is to alleviate and shorten the duration of symptoms for treated individuals, they can have a secondary effect of reducing transmission in the community. However, existing stockpiles may be insufficient for all clinical cases. Here we use simple mathematical models to present scenarios where the optimum policies to minimise morbidity and mortality, with a limited drug stockpile, are not always the most intuitively obvious and may conflict with theories of justice. We discuss ethical implications of these findings.

Keywords

Pandemic influenza Antiviral drugs Public health 

Notes

Acknowledgements

The authors gratefully acknowledge funding from the James Martin 21st Century School.

References

  1. Anderson, R.M. and R.M. May. 1992. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press.Google Scholar
  2. Arinaminpathy, N. and A.R. McLean. 2008. Antiviral treatment for the control of pandemic influenza: some logistical constraints. Journal of the Royal Society, Interface 5(22): 545–553. doi: 10.1098/rsif.2007.1152.PubMedCrossRefGoogle Scholar
  3. Australian Department of Health and Ageing. 2006. The Australian health management plan for pandemic influenza. http://www.health.gov.au/internet/main/publishing.nsf/content/phd-pandemic-plan.htm (accessed 8 May 2009).
  4. Centers for Disease Control and Prevention. 2003. Human cases of Avian Influenza A (H7N7) infection – The Netherlands, 2003. http://www.cdc.gov/flu/avian/h7n7-netherlands.htm (accessed 8 May 2009).
  5. Fan, E.X. and the Asian Development Bank. 2003. SARS: Economic impacts and implications. Singapore: ADB.Google Scholar
  6. Johnson, N.P.A.S. and J. Müller. 2002. Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic. Bulletin of the History of Medicine 76: 105–115. doi: 10.1353/bhm.2002.0022.PubMedCrossRefGoogle Scholar
  7. Jordan, E.O. 1927. Epidemic influenza: A survey. Chicago: American Medical Association.Google Scholar
  8. Kilbourne, E.D. 2006. Influenza pandemics of the 20th century. Emerg.Infect.Dis. http://www.cdc.gov/ncidod/EID/vol12no01/05-1254.htm (accessed 8 May 2009).
  9. McGeer, A., et al. 2005. Clinical features of laboratory confirmed influenza illness requiring hospital admission in Ontario, Canada: Implications for treatment recommendations. Presented at the 2005 European Scientific Working Group on Influenza (ESWI) congress, Malta. See also Commentary in Roche investor update, http://www.roche.com/inv-update-2005-09-13b
  10. Rawls, J. 1971. A theory of justice. Harvard: Harvard University Press.Google Scholar
  11. Taubenberger, J.K., D.M. Morens, and A.S. Fauci. 2007. The next influenza pandemic: can it be predicted? Journal of the American Medical Association 297: 2025–2027. doi: 10.1001/jama.297.18.2025.PubMedCrossRefGoogle Scholar
  12. UK Department of Health. 2007. Pandemic flu: a national framework for responding to an influenza pandemic. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/dh_080734 (accessed 8 May 2009).
  13. U.S. Department of Health and Human Sevices. 2005. HHS strategic plan, appendix D. http://www.hhs.gov/pandemicflu/plan/#overview (accessed 8 May 2009).
  14. Ward, P., I. Small, J. Smith, P. Suter, and R. Dutkowski. 2005. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. The Journal of Antimicrobial Chemotherapy 55(Suppl 1): i5–i21. doi: 10.1093/jac/dki018.PubMedCrossRefGoogle Scholar
  15. Wan, H., et al. 2008. Replication and transmission of H9N2 influenza viruses in ferrets: Evaluation of pandemic potential. PLoS ONE 3(8): e2923. doi: 10.1371/journal.pone.0002923.PubMedCrossRefGoogle Scholar
  16. Webby, R.J. and R.G. Webster. 2003. Are we ready for pandemic influenza? Science 302: 1519–1522. doi: 10.1126/science.1090350.PubMedCrossRefGoogle Scholar
  17. World Health Organisation. 2007. Clinical management of human infection with avian influenza A (H5N1) virus. http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07.pdf (accessed 8 May 2009).
  18. World Health Organisation. 2008. H5N1 Avian influenza: timeline of major events. http://www.who.int/csr/disease/avian_influenza/ai_timeline/en/index.html (accessed 8 May 2009)

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Nimalan Arinaminpathy
    • 1
    Email author
  • J. Savulescu
    • 2
  • Angela R. Mclean
    • 1
  1. 1.Department of ZoologyUniversity of OxfordOxfordUK
  2. 2.Oxford Uehiro Centre for Practical EthicsOxfordUK

Personalised recommendations